Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis

Yue Chen(Cedars-Sinai Medical Center), Tao Luo(Capital Medical University), Yu Li(Jinan University), Chunjing Bian(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenhao Cui(Capital Medical University), Jukun Wang(Capital Medical University), Chao Zhang(Collaborative Innovation Center of Advanced Microstructures), Luyao Jia(Capital Medical University)
Frontiers in Immunology
August 30, 2024
Cited by 9


Related Papers